Zika, Cobalamin C Deficiency Tied to Similar Retinal Problems

Share this content:
Zika, Cobalamin C Deficiency Tied to Similar Retinal Problems
Zika, Cobalamin C Deficiency Tied to Similar Retinal Problems

FRIDAY, Sept. 8, 2017 (HealthDay News) -- Retinal maldevelopment associated with congenital Zika syndrome (CZS) is similar to the maldevelopment seen with cobalamin C (cblC) deficiency, according to a study published online Sept. 7 in JAMA Opthalmology.

Tomas S. Aleman, M.D., from the University of Pennsylvania in Philadelphia, and colleagues quantified the microstructural changes of the retina in eight infants with CZS and compared these changes to those associated with cblC deficiency in eight children.

The researchers found that all eight patients with CZS had foveal abnormalities in the analyzed eyes (eight eyes), including discontinuities of the ellipsoid zone, thinning of the central retina with increased backscatter, and severe structural disorganization. Three eyes showed macular pseudocolobomas. In seven of eight eyes with a normal photoreceptor layer, pericentral retina with normal lamination showed a thinned (<30 percent of normal thickness) ganglion cell layer (GCL) that colocalized. The inner nuclear layer was normal or had borderline thinning. The central retinal degeneration was similar to that of cblC deficiency.

"The findings provide the first, to date, in vivo evidence in humans for possible retinal maldevelopment with a predilection for retinal GCL loss in CZS, consistent with a murine model of the disease and suggestive of in utero depletion of this neuronal population as a consequence of Zika virus infection," conclude the authors.

Abstract/Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »